recursion pharmaceuticals Recursion Pharmaceuticals Closes $501.8 Million Initial Public Offering Recursion Pharmaceuticals officially closes its IPO on the Nasdaq, raising $501.8 million in gross proceeds after underwriters exercise their option for additional shares. The clinical-stage biotech company trades under the ticker symbol RXRX.